However, the interruption of the renin angiotensin with ACE inhibitors or angiotensin receptor blockers (ARBs) is recommended as first line adjuvant therapy for the patients with lupus nephritis for proteinuria (Bertsias et al., 2012). This evidence concerns the gene ACE and lupus nephritis.